Forward Science Corp.(TW:7530)
NT$28.40-0.05 (-0.18%)
TW:7530
Forward Science Corp. financials statements
NT$28.40
At close:-0.05 (-0.18%)
Forward Science Corp. (7530) Ratios
Forward Science Corp. Ratios
TW:7530's free cash flow for Q2 2026 was NT$-30.66M. For the 2026 fiscal year, TW:7530's free cash flow was decreased by NT$-3.18M and operating cash flow was NT$-27.49M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.85 | 2.55 | 2.40 | 2.11 | 3.84 |
| Quick Ratio | 0.53 | 0.80 | 0.73 | 0.71 | 2.14 |
| Cash Ratio | 0.18 | 0.29 | 0.10 | 0.08 | 0.75 |
| Solvency Ratio | -0.15 | -0.09 | 0.02 | -0.10 | 0.34 |
| Operating Cash Flow Ratio | -0.11 | -0.12 | -0.10 | -0.41 | -0.25 |
| Short-Term Operating Cash Flow Coverage | -0.16 | -0.20 | -0.19 | -0.98 | -2.43 |
| Net Current Asset Value | NT$ 138.40M | NT$ 196.76M | NT$ 130.05M | NT$ 188.31M | NT$ 347.56M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.42 | 0.35 | 0.39 | 0.28 | 0.08 |
| Debt-to-Equity Ratio | 0.85 | 0.63 | 0.77 | 0.51 | 0.10 |
| Debt-to-Capital Ratio | 0.46 | 0.39 | 0.44 | 0.34 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.20 | 0.20 | 0.25 | 0.17 | 0.01 |
| Financial Leverage Ratio | 2.03 | 1.77 | 1.97 | 1.83 | 1.30 |
| Debt Service Coverage Ratio | -0.24 | -0.14 | 0.14 | -0.28 | 3.18 |
| Interest Coverage Ratio | -10.72 | -6.36 | -3.02 | -27.99 | 5.21 |
| Debt to Market Cap | 0.50 | 0.24 | 0.15 | 0.13 | 0.01 |
| Interest Debt Per Share | 8.06 | 8.65 | 9.69 | 6.75 | 1.67 |
| Net Debt to EBITDA | -5.32 | -11.24 | 15.80 | -6.57 | -0.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 8.17% | 18.91% | 23.61% | 21.83% | 43.41% |
| EBIT Margin | -48.52% | -25.45% | -6.13% | -27.10% | 6.26% |
| EBITDA Margin | -27.19% | -8.67% | 5.91% | -11.94% | 19.57% |
| Operating Profit Margin | -44.61% | -27.11% | -7.49% | -28.55% | 6.24% |
| Pretax Profit Margin | -52.68% | -30.21% | -8.92% | -28.12% | 4.62% |
| Net Profit Margin | -52.69% | -30.19% | -9.01% | -28.83% | 5.38% |
| Continuous Operations Profit Margin | -52.69% | -30.19% | -9.01% | -28.96% | 4.49% |
| Net Income Per EBT | 100.02% | 99.95% | 100.99% | 102.50% | 116.49% |
| EBT Per EBIT | 118.09% | 111.44% | 119.03% | 98.51% | 73.94% |
| Return on Assets (ROA) | -12.79% | -8.53% | -3.52% | -9.15% | 2.32% |
| Return on Equity (ROE) | -25.93% | -15.13% | -6.93% | -16.76% | 3.01% |
| Return on Capital Employed (ROCE) | -17.57% | -10.54% | -4.04% | -13.57% | 3.38% |
| Return on Invested Capital (ROIC) | -11.88% | -8.34% | -3.26% | -10.98% | 3.09% |
| Return on Tangible Assets | -12.81% | -8.55% | -3.53% | -9.22% | 2.35% |
| Earnings Yield | -16.48% | -6.63% | -1.69% | -4.73% | 0.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.02 | 2.28 | 2.62 | 1.89 | 1.71 |
| Payables Turnover | 4.52 | 6.20 | 4.73 | 2.98 | 3.28 |
| Inventory Turnover | 0.44 | 0.48 | 0.65 | 0.53 | 0.71 |
| Fixed Asset Turnover | 0.89 | 1.02 | 1.26 | 1.19 | 2.41 |
| Asset Turnover | 0.24 | 0.28 | 0.39 | 0.32 | 0.43 |
| Working Capital Turnover Ratio | 0.61 | 0.69 | 1.04 | 0.75 | 1.06 |
| Cash Conversion Cycle | 927.00 | 862.23 | 627.44 | 756.95 | 619.86 |
| Days of Sales Outstanding | 180.56 | 160.18 | 139.06 | 193.57 | 213.73 |
| Days of Inventory Outstanding | 827.15 | 760.92 | 565.50 | 685.82 | 517.57 |
| Days of Payables Outstanding | 80.71 | 58.87 | 77.13 | 122.44 | 111.44 |
| Operating Cycle | 1007.71 | 921.11 | 704.56 | 879.39 | 731.30 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.78 | -0.76 | -0.69 | -3.29 | -1.04 |
| Free Cash Flow Per Share | -1.00 | -0.88 | -0.97 | -7.08 | -1.30 |
| Dividend Paid and CapEx Coverage Ratio | -3.54 | -6.43 | -2.40 | -0.87 | -3.91 |
| Capital Expenditure Coverage Ratio | -3.54 | -6.43 | -2.40 | -0.87 | -3.91 |
| Operating Cash Flow Coverage Ratio | -0.10 | -0.09 | -0.07 | -0.49 | -0.66 |
| Operating Cash Flow to Sales Ratio | -0.17 | -0.11 | -0.07 | -0.43 | -0.12 |
| Free Cash Flow Yield | -6.88% | -2.89% | -1.94% | -15.16% | -1.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.06 | -15.07 | -59.06 | -21.13 | 149.57 |
| Price-to-Sales (P/S) Ratio | 3.20 | 4.56 | 5.32 | 6.10 | 8.11 |
| Price-to-Book (P/B) Ratio | 1.57 | 2.28 | 4.09 | 3.54 | 4.54 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.54 | -34.64 | -51.55 | -6.60 | -53.93 |
| Price-to-Operating Cash Flow Ratio | -18.65 | -40.03 | -73.02 | -14.18 | -67.71 |
| Price-to-Earnings Growth (PEG) Ratio | -0.31 | -0.11 | 0.96 | 0.04 | -1.00 |
| Enterprise Value Multiple | -17.08 | -63.78 | 105.75 | -57.66 | 40.56 |
| Enterprise Value | 774.33M | 1.18B | 1.87B | 1.66B | 2.17B |
| EV to EBITDA | -17.08 | -63.78 | 105.75 | -57.66 | 40.56 |
| EV to Sales | 4.64 | 5.53 | 6.25 | 6.88 | 7.94 |
| EV to Free Cash Flow | -21.12 | -42.05 | -60.61 | -7.45 | -52.77 |
| EV to Operating Cash Flow | -27.08 | -48.59 | -85.86 | -16.00 | -66.25 |
| Tangible Book Value Per Share | 9.25 | 13.27 | 12.16 | 12.97 | 15.12 |
| Shareholders’ Equity Per Share | 9.28 | 13.33 | 12.26 | 13.17 | 15.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | -0.01 | -0.02 | 0.03 |
| Revenue Per Share | 4.57 | 6.68 | 9.44 | 7.66 | 8.67 |
| Net Income Per Share | -2.41 | -2.02 | -0.85 | -2.21 | 0.47 |
| Tax Burden | 1.00 | 1.00 | 1.01 | 1.03 | 1.16 |
| Interest Burden | 1.09 | 1.19 | 1.45 | 1.04 | 0.74 |
| Research & Development to Revenue | 0.11 | 0.09 | 0.05 | 0.07 | 0.09 |
| SG&A to Revenue | 0.42 | 0.37 | 0.27 | 0.40 | 0.27 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.33 | 0.38 | 0.81 | 2.29 | -2.23 |
Currency in TWD
